No. Ours is completed. This is just a good look at
Post# of 72440
There is a lot there but there is only one in that list that can really compete with B-OM on the efficacy and safety side of the equation: #2 Galera's GC4419. It's an IV treatment though so even if it crosses the finish line first, our deliver mechanism will make our treatment preferred if it has the same or better efficacy.
Just need to sign a juicy B-OM deal and get back into the clinic.